Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivanib in Advanced HCC (BRISK PS)
NCT00825955Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of brivanib in hepatocellular carcinoma (HCC), sponsored by Bristol Myers Squibb. Started Feb 2009; status: completed.
02
Drugs
brivanib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00825955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825955.